Orally administered factor xa inhibitor, rivaroxaban: a novel thromboembolic prophylaxis agent.
Komotar
Ricardo J
RJ
Starke
Robert M
RM
Connolly
E Sander
ES
D000284:Administration, Oral; D001777:Blood Coagulation / Q000187:drug effects; D017984:Enoxaparin / Q000627:therapeutic use; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use*; D019637:Orthopedic Procedures / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban